Waixenicin A decreased the TRPM7 protein expression and inhibited the TRPM7-like currents in GBM cells, GBM cells showed increased apoptosis and decreased proliferation, migration, invasion and survival following treatment (Wong et al., 2020). The gene discussed is TRPM7; the disease is glioblastoma.